51
|
Kim CH, Yeom YS, Nguyen TT, Wang ZJ, Kim HS, Han MC, Lee JK, Zankl M, Petoussi-Henss N, Bolch WE, Lee C, Chung BS. The reference phantoms: voxel vs polygon. Ann ICRP 2016; 45:188-201. [PMID: 26969297 DOI: 10.1177/0146645315626036] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
The International Commission on Radiological Protection (ICRP) reference male and female adult phantoms, described in Publication 110, are voxel phantoms based on whole-body computed tomography scans of a male and a female patient, respectively. The voxel in-plane resolution and the slice thickness, of the order of a few millimetres, are insufficient for proper segmentation of smaller tissues such as the lens of the eye, the skin, and the walls of some organs. The calculated doses for these tissues therefore present some limitations, particularly for weakly penetrating radiation. Similarly, the Publication 110 phantoms cannot represent 8-40-µm-thick target regions in respiratory or alimentary tract organs. Separate stylised models have been used to represent these tissues for calculation of the ICRP reference dose coefficients (DCs). ICRP Committee 2 recently initiated a research project, the ultimate goal of which is to convert the Publication 110 phantoms to a high-quality polygon-mesh (PM) format, including all source and target regions, even those of the 8-40-µm-thick alimentary and respiratory tract organs. It is expected that the converted phantoms would lead to the same or very similar DCs as the Publication 110 reference phantoms for penetrating radiation and, at the same time, provide more accurate DCs for weakly penetrating radiation and small tissues. Additionally, the reference phantoms in the PM format would be easily deformable and, as such, could serve as a starting point to create phantoms of various postures for use, for example, in accidental dose calculations. This paper will discuss the current progress of the phantom conversion project and its significance for ICRP DC calculations.
Collapse
|
52
|
Nguyen TT, McAuley GA, Heczko S, Slater J, Wroe A. SU-F-T-211: Evaluation of a Dual Focusing Magnet System for the Treatment of Small Proton Targets. Med Phys 2016. [DOI: 10.1118/1.4956349] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
53
|
Abbott BP, Abbott R, Abbott TD, Abernathy MR, Acernese F, Ackley K, Adams C, Adams T, Addesso P, Adhikari RX, Adya VB, Affeldt C, Agathos M, Agatsuma K, Aggarwal N, Aguiar OD, Aiello L, Ain A, Ajith P, Allen B, Allocca A, Altin PA, Anderson SB, Anderson WG, Arai K, Araya MC, Arceneaux CC, Areeda JS, Arnaud N, Arun KG, Ascenzi S, Ashton G, Ast M, Aston SM, Astone P, Aufmuth P, Aulbert C, Babak S, Bacon P, Bader MKM, Baker PT, Baldaccini F, Ballardin G, Ballmer SW, Barayoga JC, Barclay SE, Barish BC, Barker D, Barone F, Barr B, Barsotti L, Barsuglia M, Barta D, Bartlett J, Bartos I, Bassiri R, Basti A, Batch JC, Baune C, Bavigadda V, Bazzan M, Behnke B, Bejger M, Bell AS, Bell CJ, Berger BK, Bergman J, Bergmann G, Berry CPL, Bersanetti D, Bertolini A, Betzwieser J, Bhagwat S, Bhandare R, Bilenko IA, Billingsley G, Birch J, Birney R, Biscans S, Bisht A, Bitossi M, Biwer C, Bizouard MA, Blackburn JK, Blair CD, Blair DG, Blair RM, Bloemen S, Bock O, Bodiya TP, Boer M, Bogaert G, Bogan C, Bohe A, Bojtos P, Bond C, Bondu F, Bonnand R, Boom BA, Bork R, Boschi V, Bose S, Bouffanais Y, Bozzi A, Bradaschia C, Brady PR, Braginsky VB, Branchesi M, Brau JE, Briant T, Brillet A, Brinkmann M, Brisson V, Brockill P, Brooks AF, Brown DD, Brown NM, Buchanan CC, Buikema A, Bulik T, Bulten HJ, Buonanno A, Buskulic D, Buy C, Byer RL, Cadonati L, Cagnoli G, Cahillane C, Bustillo JC, Callister T, Calloni E, Camp JB, Cannon KC, Cao J, Capano CD, Capocasa E, Carbognani F, Caride S, Diaz JC, Casentini C, Caudill S, Cavaglià M, Cavalier F, Cavalieri R, Cella G, Cepeda CB, Baiardi LC, Cerretani G, Cesarini E, Chakraborty R, Chalermsongsak T, Chamberlin SJ, Chan M, Chao S, Charlton P, Chassande-Mottin E, Chen HY, Chen Y, Cheng C, Chincarini A, Chiummo A, Cho HS, Cho M, Chow JH, Christensen N, Chu Q, Chua S, Chung S, Ciani G, Clara F, Clark JA, Cleva F, Coccia E, Cohadon PF, Colla A, Collette CG, Cominsky L, Constancio M, Conte A, Conti L, Cook D, Corbitt TR, Cornish N, Corsi A, Cortese S, Costa CA, Coughlin MW, Coughlin SB, Coulon JP, Countryman ST, Couvares P, Cowan EE, Coward DM, Cowart MJ, Coyne DC, Coyne R, Craig K, Creighton JDE, Cripe J, Crowder SG, Cumming A, Cunningham L, Cuoco E, Canton TD, Danilishin SL, D'Antonio S, Danzmann K, Darman NS, Dattilo V, Dave I, Daveloza HP, Davier M, Davies GS, Daw EJ, Day R, DeBra D, Debreczeni G, Degallaix J, De Laurentis M, Deléglise S, Del Pozzo W, Denker T, Dent T, Dereli H, Dergachev V, DeRosa RT, De Rosa R, DeSalvo R, Dhurandhar S, Díaz MC, Di Fiore L, Di Giovanni M, Di Lieto A, Di Pace S, Di Palma I, Di Virgilio A, Dojcinoski G, Dolique V, Donovan F, Dooley KL, Doravari S, Douglas R, Downes TP, Drago M, Drever RWP, Driggers JC, Du Z, Ducrot M, Dwyer SE, Edo TB, Edwards MC, Effler A, Eggenstein HB, Ehrens P, Eichholz J, Eikenberry SS, Engels W, Essick RC, Etzel T, Evans M, Evans TM, Everett R, Factourovich M, Fafone V, Fair H, Fairhurst S, Fan X, Fang Q, Farinon S, Farr B, Farr WM, Favata M, Fays M, Fehrmann H, Fejer MM, Ferrante I, Ferreira EC, Ferrini F, Fidecaro F, Fiori I, Fiorucci D, Fisher RP, Flaminio R, Fletcher M, Fournier JD, Franco S, Frasca S, Frasconi F, Frei Z, Freise A, Frey R, Frey V, Fricke TT, Fritschel P, Frolov VV, Fulda P, Fyffe M, Gabbard HAG, Gair JR, Gammaitoni L, Gaonkar SG, Garufi F, Gatto A, Gaur G, Gehrels N, Gemme G, Gendre B, Genin E, Gennai A, George J, Gergely L, Germain V, Ghosh A, Ghosh S, Giaime JA, Giardina KD, Giazotto A, Gill K, Glaefke A, Goetz E, Goetz R, Gondan L, González G, Castro JMG, Gopakumar A, Gordon NA, Gorodetsky ML, Gossan SE, Gosselin M, Gouaty R, Graef C, Graff PB, Granata M, Grant A, Gras S, Gray C, Greco G, Green AC, Groot P, Grote H, Grunewald S, Guidi GM, Guo X, Gupta A, Gupta MK, Gushwa KE, Gustafson EK, Gustafson R, Hacker JJ, Hall BR, Hall ED, Hammond G, Haney M, Hanke MM, Hanks J, Hanna C, Hannam MD, Hanson J, Hardwick T, Haris K, Harms J, Harry GM, Harry IW, Hart MJ, Hartman MT, Haster CJ, Haughian K, Heidmann A, Heintze MC, Heitmann H, Hello P, Hemming G, Hendry M, Heng IS, Hennig J, Heptonstall AW, Heurs M, Hild S, Hoak D, Hodge KA, Hofman D, Hollitt SE, Holt K, Holz DE, Hopkins P, Hosken DJ, Hough J, Houston EA, Howell EJ, Hu YM, Huang S, Huerta EA, Huet D, Hughey B, Husa S, Huttner SH, Huynh-Dinh T, Idrisy A, Indik N, Ingram DR, Inta R, Isa HN, Isac JM, Isi M, Islas G, Isogai T, Iyer BR, Izumi K, Jacqmin T, Jang H, Jani K, Jaranowski P, Jawahar S, Jiménez-Forteza F, Johnson WW, Jones DI, Jones R, Jonker RJG, Ju L, Kalaghatgi CV, Kalogera V, Kandhasamy S, Kang G, Kanner JB, Karki S, Kasprzack M, Katsavounidis E, Katzman W, Kaufer S, Kaur T, Kawabe K, Kawazoe F, Kéfélian F, Kehl MS, Keitel D, Kelley DB, Kells W, Kennedy R, Key JS, Khalaidovski A, Khalili FY, Khan I, Khan S, Khan Z, Khazanov EA, Kijbunchoo N, Kim C, Kim J, Kim K, Kim NG, Kim N, Kim YM, King EJ, King PJ, Kinzel DL, Kissel JS, Kleybolte L, Klimenko S, Koehlenbeck SM, Kokeyama K, Koley S, Kondrashov V, Kontos A, Korobko M, Korth WZ, Kowalska I, Kozak DB, Kringel V, Królak A, Krueger C, Kuehn G, Kumar P, Kuo L, Kutynia A, Lackey BD, Landry M, Lange J, Lantz B, Lasky PD, Lazzarini A, Lazzaro C, Leaci P, Leavey S, Lebigot EO, Lee CH, Lee HK, Lee HM, Lee K, Lenon A, Leonardi M, Leong JR, Leroy N, Letendre N, Levin Y, Levine BM, Li TGF, Libson A, Littenberg TB, Lockerbie NA, Logue J, Lombardi AL, Lord JE, Lorenzini M, Loriette V, Lormand M, Losurdo G, Lough JD, Lück H, Lundgren AP, Luo J, Lynch R, Ma Y, MacDonald T, Machenschalk B, MacInnis M, Macleod DM, Magaña-Sandoval F, Magee RM, Mageswaran M, Majorana E, Maksimovic I, Malvezzi V, Man N, Mandel I, Mandic V, Mangano V, Mansell GL, Manske M, Mantovani M, Marchesoni F, Marion F, Márka S, Márka Z, Markosyan AS, Maros E, Martelli F, Martellini L, Martin IW, Martin RM, Martynov DV, Marx JN, Mason K, Masserot A, Massinger TJ, Masso-Reid M, Matichard F, Matone L, Mavalvala N, Mazumder N, Mazzolo G, McCarthy R, McClelland DE, McCormick S, McGuire SC, McIntyre G, McIver J, McManus DJ, McWilliams ST, Meacher D, Meadors GD, Meidam J, Melatos A, Mendell G, Mendoza-Gandara D, Mercer RA, Merilh E, Merzougui M, Meshkov S, Messenger C, Messick C, Meyers PM, Mezzani F, Miao H, Michel C, Middleton H, Mikhailov EE, Milano L, Miller J, Millhouse M, Minenkov Y, Ming J, Mirshekari S, Mishra C, Mitra S, Mitrofanov VP, Mitselmakher G, Mittleman R, Moggi A, Mohan M, Mohapatra SRP, Montani M, Moore BC, Moore CJ, Moraru D, Moreno G, Morriss SR, Mossavi K, Mours B, Mow-Lowry CM, Mueller CL, Mueller G, Muir AW, Mukherjee A, Mukherjee D, Mukherjee S, Mukund N, Mullavey A, Munch J, Murphy DJ, Murray PG, Mytidis A, Nardecchia I, Naticchioni L, Nayak RK, Necula V, Nedkova K, Nelemans G, Neri M, Neunzert A, Newton G, Nguyen TT, Nielsen AB, Nissanke S, Nitz A, Nocera F, Nolting D, Normandin MEN, Nuttall LK, Oberling J, Ochsner E, O'Dell J, Oelker E, Ogin GH, Oh JJ, Oh SH, Ohme F, Oliver M, Oppermann P, Oram RJ, O'Reilly B, O'Shaughnessy R, Ottaway DJ, Ottens RS, Overmier H, Owen BJ, Pai A, Pai SA, Palamos JR, Palashov O, Palomba C, Pal-Singh A, Pan H, Pankow C, Pannarale F, Pant BC, Paoletti F, Paoli A, Papa MA, Paris HR, Parker W, Pascucci D, Pasqualetti A, Passaquieti R, Passuello D, Patricelli B, Patrick Z, Pearlstone BL, Pedraza M, Pedurand R, Pekowsky L, Pele A, Penn S, Perreca A, Phelps M, Piccinni O, Pichot M, Piergiovanni F, Pierro V, Pillant G, Pinard L, Pinto IM, Pitkin M, Poggiani R, Popolizio P, Post A, Powell J, Prasad J, Predoi V, Premachandra SS, Prestegard T, Price LR, Prijatelj M, Principe M, Privitera S, Prodi GA, Prokhorov L, Puncken O, Punturo M, Puppo P, Pürrer M, Qi H, Qin J, Quetschke V, Quintero EA, Quitzow-James R, Raab FJ, Rabeling DS, Radkins H, Raffai P, Raja S, Rakhmanov M, Rapagnani P, Raymond V, Razzano M, Re V, Read J, Reed CM, Regimbau T, Rei L, Reid S, Reitze DH, Rew H, Reyes SD, Ricci F, Riles K, Robertson NA, Robie R, Robinet F, Rocchi A, Rolland L, Rollins JG, Roma VJ, Romano JD, Romano R, Romanov G, Romie JH, Rosińska D, Rowan S, Rüdiger A, Ruggi P, Ryan K, Sachdev S, Sadecki T, Sadeghian L, Salconi L, Saleem M, Salemi F, Samajdar A, Sammut L, Sanchez EJ, Sandberg V, Sandeen B, Sanders JR, Sassolas B, Sathyaprakash BS, Saulson PR, Sauter O, Savage RL, Sawadsky A, Schale P, Schilling R, Schmidt J, Schmidt P, Schnabel R, Schofield RMS, Schönbeck A, Schreiber E, Schuette D, Schutz BF, Scott J, Scott SM, Sellers D, Sentenac D, Sequino V, Sergeev A, Serna G, Setyawati Y, Sevigny A, Shaddock DA, Shah S, Shahriar MS, Shaltev M, Shao Z, Shapiro B, Shawhan P, Sheperd A, Shoemaker DH, Shoemaker DM, Siellez K, Siemens X, Sigg D, Silva AD, Simakov D, Singer A, Singer LP, Singh A, Singh R, Singhal A, Sintes AM, Slagmolen BJJ, Smith JR, Smith ND, Smith RJE, Son EJ, Sorazu B, Sorrentino F, Souradeep T, Srivastava AK, Staley A, Steinke M, Steinlechner J, Steinlechner S, Steinmeyer D, Stephens BC, Stone R, Strain KA, Straniero N, Stratta G, Strauss NA, Strigin S, Sturani R, Stuver AL, Summerscales TZ, Sun L, Sutton PJ, Swinkels BL, Szczepańczyk MJ, Tacca M, Talukder D, Tanner DB, Tápai M, Tarabrin SP, Taracchini A, Taylor R, Theeg T, Thirugnanasambandam MP, Thomas EG, Thomas M, Thomas P, Thorne KA, Thorne KS, Thrane E, Tiwari S, Tiwari V, Tokmakov KV, Tomlinson C, Tonelli M, Torres CV, Torrie CI, Töyrä D, Travasso F, Traylor G, Trifirò D, Tringali MC, Trozzo L, Tse M, Turconi M, Tuyenbayev D, Ugolini D, Unnikrishnan CS, Urban AL, Usman SA, Vahlbruch H, Vajente G, Valdes G, van Bakel N, van Beuzekom M, van den Brand JFJ, Van Den Broeck C, Vander-Hyde DC, van der Schaaf L, van Heijningen JV, van Veggel AA, Vardaro M, Vass S, Vasúth M, Vaulin R, Vecchio A, Vedovato G, Veitch J, Veitch PJ, Venkateswara K, Verkindt D, Vetrano F, Viceré A, Vinciguerra S, Vine DJ, Vinet JY, Vitale S, Vo T, Vocca H, Vorvick C, Voss D, Vousden WD, Vyatchanin SP, Wade AR, Wade LE, Wade M, Walker M, Wallace L, Walsh S, Wang G, Wang H, Wang M, Wang X, Wang Y, Ward RL, Warner J, Was M, Weaver B, Wei LW, Weinert M, Weinstein AJ, Weiss R, Welborn T, Wen L, Weßels P, Westphal T, Wette K, Whelan JT, White DJ, Whiting BF, Williams RD, Williamson AR, Willis JL, Willke B, Wimmer MH, Winkler W, Wipf CC, Wittel H, Woan G, Worden J, Wright JL, Wu G, Yablon J, Yam W, Yamamoto H, Yancey CC, Yap MJ, Yu H, Yvert M, Zadrożny A, Zangrando L, Zanolin M, Zendri JP, Zevin M, Zhang F, Zhang L, Zhang M, Zhang Y, Zhao C, Zhou M, Zhou Z, Zhu XJ, Zucker ME, Zuraw SE, Zweizig J. GW150914: Implications for the Stochastic Gravitational-Wave Background from Binary Black Holes. PHYSICAL REVIEW LETTERS 2016; 116:131102. [PMID: 27081965 DOI: 10.1103/physrevlett.116.131102] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/13/2016] [Indexed: 06/05/2023]
Abstract
The LIGO detection of the gravitational wave transient GW150914, from the inspiral and merger of two black holes with masses ≳30M_{⊙}, suggests a population of binary black holes with relatively high mass. This observation implies that the stochastic gravitational-wave background from binary black holes, created from the incoherent superposition of all the merging binaries in the Universe, could be higher than previously expected. Using the properties of GW150914, we estimate the energy density of such a background from binary black holes. In the most sensitive part of the Advanced LIGO and Advanced Virgo band for stochastic backgrounds (near 25 Hz), we predict Ω_{GW}(f=25 Hz)=1.1_{-0.9}^{+2.7}×10^{-9} with 90% confidence. This prediction is robustly demonstrated for a variety of formation scenarios with different parameters. The differences between models are small compared to the statistical uncertainty arising from the currently poorly constrained local coalescence rate. We conclude that this background is potentially measurable by the Advanced LIGO and Advanced Virgo detectors operating at their projected final sensitivity.
Collapse
|
54
|
Abbott BP, Abbott R, Abbott TD, Abernathy MR, Acernese F, Ackley K, Adams C, Adams T, Addesso P, Adhikari RX, Adya VB, Affeldt C, Agathos M, Agatsuma K, Aggarwal N, Aguiar OD, Aiello L, Ain A, Ajith P, Allen B, Allocca A, Altin PA, Anderson SB, Anderson WG, Arai K, Araya MC, Arceneaux CC, Areeda JS, Arnaud N, Arun KG, Ascenzi S, Ashton G, Ast M, Aston SM, Astone P, Aufmuth P, Aulbert C, Babak S, Bacon P, Bader MKM, Baker PT, Baldaccini F, Ballardin G, Ballmer SW, Barayoga JC, Barclay SE, Barish BC, Barker D, Barone F, Barr B, Barsotti L, Barsuglia M, Barta D, Bartlett J, Bartos I, Bassiri R, Basti A, Batch JC, Baune C, Bavigadda V, Bazzan M, Behnke B, Bejger M, Bell AS, Bell CJ, Berger BK, Bergman J, Bergmann G, Berry CPL, Bersanetti D, Bertolini A, Betzwieser J, Bhagwat S, Bhandare R, Bilenko IA, Billingsley G, Birch J, Birney R, Biscans S, Bisht A, Bitossi M, Biwer C, Bizouard MA, Blackburn JK, Blair CD, Blair DG, Blair RM, Bloemen S, Bock O, Bodiya TP, Boer M, Bogaert G, Bogan C, Bohe A, Bojtos P, Bond C, Bondu F, Bonnand R, Boom BA, Bork R, Boschi V, Bose S, Bouffanais Y, Bozzi A, Bradaschia C, Brady PR, Braginsky VB, Branchesi M, Brau JE, Briant T, Brillet A, Brinkmann M, Brisson V, Brockill P, Brooks AF, Brown DA, Brown DD, Brown NM, Buchanan CC, Buikema A, Bulik T, Bulten HJ, Buonanno A, Buskulic D, Buy C, Byer RL, Cadonati L, Cagnoli G, Cahillane C, Calderón Bustillo J, Callister T, Calloni E, Camp JB, Cannon KC, Cao J, Capano CD, Capocasa E, Carbognani F, Caride S, Casanueva Diaz J, Casentini C, Caudill S, Cavaglià M, Cavalier F, Cavalieri R, Cella G, Cepeda CB, Cerboni Baiardi L, Cerretani G, Cesarini E, Chakraborty R, Chalermsongsak T, Chamberlin SJ, Chan M, Chao S, Charlton P, Chassande-Mottin E, Chen HY, Chen Y, Cheng C, Chincarini A, Chiummo A, Cho HS, Cho M, Chow JH, Christensen N, Chu Q, Chua S, Chung S, Ciani G, Clara F, Clark JA, Cleva F, Coccia E, Cohadon PF, Colla A, Collette CG, Cominsky L, Constancio M, Conte A, Conti L, Cook D, Corbitt TR, Cornish N, Corsi A, Cortese S, Costa CA, Coughlin MW, Coughlin SB, Coulon JP, Countryman ST, Couvares P, Cowan EE, Coward DM, Cowart MJ, Coyne DC, Coyne R, Craig K, Creighton JDE, Cripe J, Crowder SG, Cumming A, Cunningham L, Cuoco E, Dal Canton T, Danilishin SL, D'Antonio S, Danzmann K, Darman NS, Dattilo V, Dave I, Daveloza HP, Davier M, Davies GS, Daw EJ, Day R, DeBra D, Debreczeni G, Degallaix J, De Laurentis M, Deléglise S, Del Pozzo W, Denker T, Dent T, Dereli H, Dergachev V, DeRosa RT, De Rosa R, DeSalvo R, Dhurandhar S, Díaz MC, Di Fiore L, Di Giovanni M, Di Lieto A, Di Pace S, Di Palma I, Di Virgilio A, Dojcinoski G, Dolique V, Donovan F, Dooley KL, Doravari S, Douglas R, Downes TP, Drago M, Drever RWP, Driggers JC, Du Z, Ducrot M, Dwyer SE, Edo TB, Edwards MC, Effler A, Eggenstein HB, Ehrens P, Eichholz J, Eikenberry SS, Engels W, Essick RC, Etzel T, Evans M, Evans TM, Everett R, Factourovich M, Fafone V, Fair H, Fairhurst S, Fan X, Fang Q, Farinon S, Farr B, Farr WM, Favata M, Fays M, Fehrmann H, Fejer MM, Ferrante I, Ferreira EC, Ferrini F, Fidecaro F, Fiori I, Fiorucci D, Fisher RP, Flaminio R, Fletcher M, Fournier JD, Franco S, Frasca S, Frasconi F, Frei Z, Freise A, Frey R, Frey V, Fricke TT, Fritschel P, Frolov VV, Fulda P, Fyffe M, Gabbard HAG, Gair JR, Gammaitoni L, Gaonkar SG, Garufi F, Gatto A, Gaur G, Gehrels N, Gemme G, Gendre B, Genin E, Gennai A, George J, Gergely L, Germain V, Ghosh A, Ghosh S, Giaime JA, Giardina KD, Giazotto A, Gill K, Glaefke A, Goetz E, Goetz R, Gondan L, González G, Gonzalez Castro JM, Gopakumar A, Gordon NA, Gorodetsky ML, Gossan SE, Gosselin M, Gouaty R, Graef C, Graff PB, Granata M, Grant A, Gras S, Gray C, Greco G, Green AC, Groot P, Grote H, Grunewald S, Guidi GM, Guo X, Gupta A, Gupta MK, Gushwa KE, Gustafson EK, Gustafson R, Hacker JJ, Hall BR, Hall ED, Hammond G, Haney M, Hanke MM, Hanks J, Hanna C, Hannam MD, Hanson J, Hardwick T, Haris K, Harms J, Harry GM, Harry IW, Hart MJ, Hartman MT, Haster CJ, Haughian K, Heidmann A, Heintze MC, Heitmann H, Hello P, Hemming G, Hendry M, Heng IS, Hennig J, Heptonstall AW, Heurs M, Hild S, Hoak D, Hodge KA, Hofman D, Hollitt SE, Holt K, Holz DE, Hopkins P, Hosken DJ, Hough J, Houston EA, Howell EJ, Hu YM, Huang S, Huerta EA, Huet D, Hughey B, Husa S, Huttner SH, Huynh-Dinh T, Idrisy A, Indik N, Ingram DR, Inta R, Isa HN, Isac JM, Isi M, Islas G, Isogai T, Iyer BR, Izumi K, Jacqmin T, Jang H, Jani K, Jaranowski P, Jawahar S, Jiménez-Forteza F, Johnson WW, Jones DI, Jones R, Jonker RJG, Ju L, Kalaghatgi CV, Kalogera V, Kandhasamy S, Kang G, Kanner JB, Karki S, Kasprzack M, Katsavounidis E, Katzman W, Kaufer S, Kaur T, Kawabe K, Kawazoe F, Kéfélian F, Kehl MS, Keitel D, Kelley DB, Kells W, Kennedy R, Key JS, Khalaidovski A, Khalili FY, Khan I, Khan S, Khan Z, Khazanov EA, Kijbunchoo N, Kim C, Kim J, Kim K, Kim NG, Kim N, Kim YM, King EJ, King PJ, Kinzel DL, Kissel JS, Kleybolte L, Klimenko S, Koehlenbeck SM, Kokeyama K, Koley S, Kondrashov V, Kontos A, Korobko M, Korth WZ, Kowalska I, Kozak DB, Kringel V, Królak A, Krueger C, Kuehn G, Kumar P, Kuo L, Kutynia A, Lackey BD, Landry M, Lange J, Lantz B, Lasky PD, Lazzarini A, Lazzaro C, Leaci P, Leavey S, Lebigot EO, Lee CH, Lee HK, Lee HM, Lee K, Lenon A, Leonardi M, Leong JR, Leroy N, Letendre N, Levin Y, Levine BM, Li TGF, Libson A, Littenberg TB, Lockerbie NA, Logue J, Lombardi AL, Lord JE, Lorenzini M, Loriette V, Lormand M, Losurdo G, Lough JD, Lück H, Lundgren AP, Luo J, Lynch R, Ma Y, MacDonald T, Machenschalk B, MacInnis M, Macleod DM, Magaña-Sandoval F, Magee RM, Mageswaran M, Majorana E, Maksimovic I, Malvezzi V, Man N, Mandel I, Mandic V, Mangano V, Mansell GL, Manske M, Mantovani M, Marchesoni F, Marion F, Márka S, Márka Z, Markosyan AS, Maros E, Martelli F, Martellini L, Martin IW, Martin RM, Martynov DV, Marx JN, Mason K, Masserot A, Massinger TJ, Masso-Reid M, Matichard F, Matone L, Mavalvala N, Mazumder N, Mazzolo G, McCarthy R, McClelland DE, McCormick S, McGuire SC, McIntyre G, McIver J, McManus DJ, McWilliams ST, Meacher D, Meadors GD, Meidam J, Melatos A, Mendell G, Mendoza-Gandara D, Mercer RA, Merilh E, Merzougui M, Meshkov S, Messenger C, Messick C, Meyers PM, Mezzani F, Miao H, Michel C, Middleton H, Mikhailov EE, Milano L, Miller J, Millhouse M, Minenkov Y, Ming J, Mirshekari S, Mishra C, Mitra S, Mitrofanov VP, Mitselmakher G, Mittleman R, Moggi A, Mohan M, Mohapatra SRP, Montani M, Moore BC, Moore CJ, Moraru D, Moreno G, Morriss SR, Mossavi K, Mours B, Mow-Lowry CM, Mueller CL, Mueller G, Muir AW, Mukherjee A, Mukherjee D, Mukherjee S, Mukund N, Mullavey A, Munch J, Murphy DJ, Murray PG, Mytidis A, Nardecchia I, Naticchioni L, Nayak RK, Necula V, Nedkova K, Nelemans G, Neri M, Neunzert A, Newton G, Nguyen TT, Nielsen AB, Nissanke S, Nitz A, Nocera F, Nolting D, Normandin ME, Nuttall LK, Oberling J, Ochsner E, O'Dell J, Oelker E, Ogin GH, Oh JJ, Oh SH, Ohme F, Oliver M, Oppermann P, Oram RJ, O'Reilly B, O'Shaughnessy R, Ottaway DJ, Ottens RS, Overmier H, Owen BJ, Pai A, Pai SA, Palamos JR, Palashov O, Palomba C, Pal-Singh A, Pan H, Pankow C, Pannarale F, Pant BC, Paoletti F, Paoli A, Papa MA, Paris HR, Parker W, Pascucci D, Pasqualetti A, Passaquieti R, Passuello D, Patricelli B, Patrick Z, Pearlstone BL, Pedraza M, Pedurand R, Pekowsky L, Pele A, Penn S, Perreca A, Phelps M, Piccinni O, Pichot M, Piergiovanni F, Pierro V, Pillant G, Pinard L, Pinto IM, Pitkin M, Poggiani R, Popolizio P, Post A, Powell J, Prasad J, Predoi V, Premachandra SS, Prestegard T, Price LR, Prijatelj M, Principe M, Privitera S, Prodi GA, Prokhorov L, Puncken O, Punturo M, Puppo P, Pürrer M, Qi H, Qin J, Quetschke V, Quintero EA, Quitzow-James R, Raab FJ, Rabeling DS, Radkins H, Raffai P, Raja S, Rakhmanov M, Rapagnani P, Raymond V, Razzano M, Re V, Read J, Reed CM, Regimbau T, Rei L, Reid S, Reitze DH, Rew H, Reyes SD, Ricci F, Riles K, Robertson NA, Robie R, Robinet F, Rocchi A, Rolland L, Rollins JG, Roma VJ, Romano R, Romanov G, Romie JH, Rosińska D, Rowan S, Rüdiger A, Ruggi P, Ryan K, Sachdev S, Sadecki T, Sadeghian L, Salconi L, Saleem M, Salemi F, Samajdar A, Sammut L, Sanchez EJ, Sandberg V, Sandeen B, Sanders JR, Sassolas B, Sathyaprakash BS, Saulson PR, Sauter O, Savage RL, Sawadsky A, Schale P, Schilling R, Schmidt J, Schmidt P, Schnabel R, Schofield RMS, Schönbeck A, Schreiber E, Schuette D, Schutz BF, Scott J, Scott SM, Sellers D, Sengupta AS, Sentenac D, Sequino V, Sergeev A, Serna G, Setyawati Y, Sevigny A, Shaddock DA, Shah S, Shahriar MS, Shaltev M, Shao Z, Shapiro B, Shawhan P, Sheperd A, Shoemaker DH, Shoemaker DM, Siellez K, Siemens X, Sigg D, Silva AD, Simakov D, Singer A, Singer LP, Singh A, Singh R, Singhal A, Sintes AM, Slagmolen BJJ, Smith JR, Smith ND, Smith RJE, Son EJ, Sorazu B, Sorrentino F, Souradeep T, Srivastava AK, Staley A, Steinke M, Steinlechner J, Steinlechner S, Steinmeyer D, Stephens BC, Stone R, Strain KA, Straniero N, Stratta G, Strauss NA, Strigin S, Sturani R, Stuver AL, Summerscales TZ, Sun L, Sutton PJ, Swinkels BL, Szczepańczyk MJ, Tacca M, Talukder D, Tanner DB, Tápai M, Tarabrin SP, Taracchini A, Taylor R, Theeg T, Thirugnanasambandam MP, Thomas EG, Thomas M, Thomas P, Thorne KA, Thorne KS, Thrane E, Tiwari S, Tiwari V, Tokmakov KV, Tomlinson C, Tonelli M, Torres CV, Torrie CI, Töyrä D, Travasso F, Traylor G, Trifirò D, Tringali MC, Trozzo L, Tse M, Turconi M, Tuyenbayev D, Ugolini D, Unnikrishnan CS, Urban AL, Usman SA, Vahlbruch H, Vajente G, Valdes G, van Bakel N, van Beuzekom M, van den Brand JFJ, Van Den Broeck C, Vander-Hyde DC, van der Schaaf L, van Heijningen JV, van Veggel AA, Vardaro M, Vass S, Vasúth M, Vaulin R, Vecchio A, Vedovato G, Veitch J, Veitch PJ, Venkateswara K, Verkindt D, Vetrano F, Viceré A, Vinciguerra S, Vine DJ, Vinet JY, Vitale S, Vo T, Vocca H, Vorvick C, Voss D, Vousden WD, Vyatchanin SP, Wade AR, Wade LE, Wade M, Walker M, Wallace L, Walsh S, Wang G, Wang H, Wang M, Wang X, Wang Y, Ward RL, Warner J, Was M, Weaver B, Wei LW, Weinert M, Weinstein AJ, Weiss R, Welborn T, Wen L, Weßels P, Westphal T, Wette K, Whelan JT, Whitcomb SE, White DJ, Whiting BF, Williams RD, Williamson AR, Willis JL, Willke B, Wimmer MH, Winkler W, Wipf CC, Wittel H, Woan G, Worden J, Wright JL, Wu G, Yablon J, Yam W, Yamamoto H, Yancey CC, Yap MJ, Yu H, Yvert M, Zadrożny A, Zangrando L, Zanolin M, Zendri JP, Zevin M, Zhang F, Zhang L, Zhang M, Zhang Y, Zhao C, Zhou M, Zhou Z, Zhu XJ, Zucker ME, Zuraw SE, Zweizig J. GW150914: The Advanced LIGO Detectors in the Era of First Discoveries. PHYSICAL REVIEW LETTERS 2016; 116:131103. [PMID: 27081966 DOI: 10.1103/physrevlett.116.131103] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/15/2016] [Indexed: 05/21/2023]
Abstract
Following a major upgrade, the two advanced detectors of the Laser Interferometer Gravitational-wave Observatory (LIGO) held their first observation run between September 2015 and January 2016. With a strain sensitivity of 10^{-23}/sqrt[Hz] at 100 Hz, the product of observable volume and measurement time exceeded that of all previous runs within the first 16 days of coincident observation. On September 14, 2015, the Advanced LIGO detectors observed a transient gravitational-wave signal determined to be the coalescence of two black holes [B. P. Abbott et al., Phys. Rev. Lett. 116, 061102 (2016)], launching the era of gravitational-wave astronomy. The event, GW150914, was observed with a combined signal-to-noise ratio of 24 in coincidence by the two detectors. Here, we present the main features of the detectors that enabled this observation. At full sensitivity, the Advanced LIGO detectors are designed to deliver another factor of 3 improvement in the signal-to-noise ratio for binary black hole systems similar in mass to GW150914.
Collapse
|
55
|
Abbott BP, Abbott R, Abbott TD, Abernathy MR, Acernese F, Ackley K, Adams C, Adams T, Addesso P, Adhikari RX, Adya VB, Affeldt C, Agathos M, Agatsuma K, Aggarwal N, Aguiar OD, Aiello L, Ain A, Ajith P, Allen B, Allocca A, Altin PA, Anderson SB, Anderson WG, Arai K, Arain MA, Araya MC, Arceneaux CC, Areeda JS, Arnaud N, Arun KG, Ascenzi S, Ashton G, Ast M, Aston SM, Astone P, Aufmuth P, Aulbert C, Babak S, Bacon P, Bader MKM, Baker PT, Baldaccini F, Ballardin G, Ballmer SW, Barayoga JC, Barclay SE, Barish BC, Barker D, Barone F, Barr B, Barsotti L, Barsuglia M, Barta D, Bartlett J, Barton MA, Bartos I, Bassiri R, Basti A, Batch JC, Baune C, Bavigadda V, Bazzan M, Behnke B, Bejger M, Belczynski C, Bell AS, Bell CJ, Berger BK, Bergman J, Bergmann G, Berry CPL, Bersanetti D, Bertolini A, Betzwieser J, Bhagwat S, Bhandare R, Bilenko IA, Billingsley G, Birch J, Birney R, Birnholtz O, Biscans S, Bisht A, Bitossi M, Biwer C, Bizouard MA, Blackburn JK, Blair CD, Blair DG, Blair RM, Bloemen S, Bock O, Bodiya TP, Boer M, Bogaert G, Bogan C, Bohe A, Bojtos P, Bond C, Bondu F, Bonnand R, Boom BA, Bork R, Boschi V, Bose S, Bouffanais Y, Bozzi A, Bradaschia C, Brady PR, Braginsky VB, Branchesi M, Brau JE, Briant T, Brillet A, Brinkmann M, Brisson V, Brockill P, Brooks AF, Brown DA, Brown DD, Brown NM, Buchanan CC, Buikema A, Bulik T, Bulten HJ, Buonanno A, Buskulic D, Buy C, Byer RL, Cabero M, Cadonati L, Cagnoli G, Cahillane C, Calderón Bustillo J, Callister T, Calloni E, Camp JB, Cannon KC, Cao J, Capano CD, Capocasa E, Carbognani F, Caride S, Casanueva Diaz J, Casentini C, Caudill S, Cavaglià M, Cavalier F, Cavalieri R, Cella G, Cepeda CB, Cerboni Baiardi L, Cerretani G, Cesarini E, Chakraborty R, Chalermsongsak T, Chamberlin SJ, Chan M, Chao S, Charlton P, Chassande-Mottin E, Chen HY, Chen Y, Cheng C, Chincarini A, Chiummo A, Cho HS, Cho M, Chow JH, Christensen N, Chu Q, Chua S, Chung S, Ciani G, Clara F, Clark JA, Cleva F, Coccia E, Cohadon PF, Colla A, Collette CG, Cominsky L, Constancio M, Conte A, Conti L, Cook D, Corbitt TR, Cornish N, Corsi A, Cortese S, Costa CA, Coughlin MW, Coughlin SB, Coulon JP, Countryman ST, Couvares P, Cowan EE, Coward DM, Cowart MJ, Coyne DC, Coyne R, Craig K, Creighton JDE, Creighton TD, Cripe J, Crowder SG, Cruise AM, Cumming A, Cunningham L, Cuoco E, Dal Canton T, Danilishin SL, D'Antonio S, Danzmann K, Darman NS, Da Silva Costa CF, Dattilo V, Dave I, Daveloza HP, Davier M, Davies GS, Daw EJ, Day R, De S, DeBra D, Debreczeni G, Degallaix J, De Laurentis M, Deléglise S, Del Pozzo W, Denker T, Dent T, Dereli H, Dergachev V, DeRosa RT, De Rosa R, DeSalvo R, Dhurandhar S, Díaz MC, Di Fiore L, Di Giovanni M, Di Lieto A, Di Pace S, Di Palma I, Di Virgilio A, Dojcinoski G, Dolique V, Donovan F, Dooley KL, Doravari S, Douglas R, Downes TP, Drago M, Drever RWP, Driggers JC, Du Z, Ducrot M, Dwyer SE, Edo TB, Edwards MC, Effler A, Eggenstein HB, Ehrens P, Eichholz J, Eikenberry SS, Engels W, Essick RC, Etzel T, Evans M, Evans TM, Everett R, Factourovich M, Fafone V, Fair H, Fairhurst S, Fan X, Fang Q, Farinon S, Farr B, Farr WM, Favata M, Fays M, Fehrmann H, Fejer MM, Feldbaum D, Ferrante I, Ferreira EC, Ferrini F, Fidecaro F, Finn LS, Fiori I, Fiorucci D, Fisher RP, Flaminio R, Fletcher M, Fong H, Fournier JD, Franco S, Frasca S, Frasconi F, Frede M, Frei Z, Freise A, Frey R, Frey V, Fricke TT, Fritschel P, Frolov VV, Fulda P, Fyffe M, Gabbard HAG, Gair JR, Gammaitoni L, Gaonkar SG, Garufi F, Gatto A, Gaur G, Gehrels N, Gemme G, Gendre B, Genin E, Gennai A, George J, Gergely L, Germain V, Ghosh A, Ghosh A, Ghosh S, Giaime JA, Giardina KD, Giazotto A, Gill K, Glaefke A, Gleason JR, Goetz E, Goetz R, Gondan L, González G, Gonzalez Castro JM, Gopakumar A, Gordon NA, Gorodetsky ML, Gossan SE, Gosselin M, Gouaty R, Graef C, Graff PB, Granata M, Grant A, Gras S, Gray C, Greco G, Green AC, Greenhalgh RJS, Groot P, Grote H, Grunewald S, Guidi GM, Guo X, Gupta A, Gupta MK, Gushwa KE, Gustafson EK, Gustafson R, Hacker JJ, Hall BR, Hall ED, Hammond G, Haney M, Hanke MM, Hanks J, Hanna C, Hannam MD, Hanson J, Hardwick T, Harms J, Harry GM, Harry IW, Hart MJ, Hartman MT, Haster CJ, Haughian K, Healy J, Heefner J, Heidmann A, Heintze MC, Heinzel G, Heitmann H, Hello P, Hemming G, Hendry M, Heng IS, Hennig J, Heptonstall AW, Heurs M, Hild S, Hoak D, Hodge KA, Hofman D, Hollitt SE, Holt K, Holz DE, Hopkins P, Hosken DJ, Hough J, Houston EA, Howell EJ, Hu YM, Huang S, Huerta EA, Huet D, Hughey B, Husa S, Huttner SH, Huynh-Dinh T, Idrisy A, Indik N, Ingram DR, Inta R, Isa HN, Isac JM, Isi M, Islas G, Isogai T, Iyer BR, Izumi K, Jacobson MB, Jacqmin T, Jang H, Jani K, Jaranowski P, Jawahar S, Jiménez-Forteza F, Johnson WW, Johnson-McDaniel NK, Jones DI, Jones R, Jonker RJG, Ju L, Haris K, Kalaghatgi CV, Kalogera V, Kandhasamy S, Kang G, Kanner JB, Karki S, Kasprzack M, Katsavounidis E, Katzman W, Kaufer S, Kaur T, Kawabe K, Kawazoe F, Kéfélian F, Kehl MS, Keitel D, Kelley DB, Kells W, Kennedy R, Keppel DG, Key JS, Khalaidovski A, Khalili FY, Khan I, Khan S, Khan Z, Khazanov EA, Kijbunchoo N, Kim C, Kim J, Kim K, Kim NG, Kim N, Kim YM, King EJ, King PJ, Kinzel DL, Kissel JS, Kleybolte L, Klimenko S, Koehlenbeck SM, Kokeyama K, Koley S, Kondrashov V, Kontos A, Koranda S, Korobko M, Korth WZ, Kowalska I, Kozak DB, Kringel V, Krishnan B, Królak A, Krueger C, Kuehn G, Kumar P, Kumar R, Kuo L, Kutynia A, Kwee P, Lackey BD, Landry M, Lange J, Lantz B, Lasky PD, Lazzarini A, Lazzaro C, Leaci P, Leavey S, Lebigot EO, Lee CH, Lee HK, Lee HM, Lee K, Lenon A, Leonardi M, Leong JR, Leroy N, Letendre N, Levin Y, Levine BM, Li TGF, Libson A, Littenberg TB, Lockerbie NA, Logue J, Lombardi AL, London LT, Lord JE, Lorenzini M, Loriette V, Lormand M, Losurdo G, Lough JD, Lousto CO, Lovelace G, Lück H, Lundgren AP, Luo J, Lynch R, Ma Y, MacDonald T, Machenschalk B, MacInnis M, Macleod DM, Magaña-Sandoval F, Magee RM, Mageswaran M, Majorana E, Maksimovic I, Malvezzi V, Man N, Mandel I, Mandic V, Mangano V, Mansell GL, Manske M, Mantovani M, Marchesoni F, Marion F, Márka S, Márka Z, Markosyan AS, Maros E, Martelli F, Martellini L, Martin IW, Martin RM, Martynov DV, Marx JN, Mason K, Masserot A, Massinger TJ, Masso-Reid M, Matichard F, Matone L, Mavalvala N, Mazumder N, Mazzolo G, McCarthy R, McClelland DE, McCormick S, McGuire SC, McIntyre G, McIver J, McManus DJ, McWilliams ST, Meacher D, Meadors GD, Meidam J, Melatos A, Mendell G, Mendoza-Gandara D, Mercer RA, Merilh E, Merzougui M, Meshkov S, Messenger C, Messick C, Meyers PM, Mezzani F, Miao H, Michel C, Middleton H, Mikhailov EE, Milano L, Miller J, Millhouse M, Minenkov Y, Ming J, Mirshekari S, Mishra C, Mitra S, Mitrofanov VP, Mitselmakher G, Mittleman R, Moggi A, Mohan M, Mohapatra SRP, Montani M, Moore BC, Moore CJ, Moraru D, Moreno G, Morriss SR, Mossavi K, Mours B, Mow-Lowry CM, Mueller CL, Mueller G, Muir AW, Mukherjee A, Mukherjee D, Mukherjee S, Mukund N, Mullavey A, Munch J, Murphy DJ, Murray PG, Mytidis A, Nardecchia I, Naticchioni L, Nayak RK, Necula V, Nedkova K, Nelemans G, Neri M, Neunzert A, Newton G, Nguyen TT, Nielsen AB, Nissanke S, Nitz A, Nocera F, Nolting D, Normandin MEN, Nuttall LK, Oberling J, Ochsner E, O'Dell J, Oelker E, Ogin GH, Oh JJ, Oh SH, Ohme F, Oliver M, Oppermann P, Oram RJ, O'Reilly B, O'Shaughnessy R, Ott CD, Ottaway DJ, Ottens RS, Overmier H, Owen BJ, Pai A, Pai SA, Palamos JR, Palashov O, Palomba C, Pal-Singh A, Pan H, Pan Y, Pankow C, Pannarale F, Pant BC, Paoletti F, Paoli A, Papa MA, Paris HR, Parker W, Pascucci D, Pasqualetti A, Passaquieti R, Passuello D, Patricelli B, Patrick Z, Pearlstone BL, Pedraza M, Pedurand R, Pekowsky L, Pele A, Penn S, Perreca A, Pfeiffer HP, Phelps M, Piccinni O, Pichot M, Pickenpack M, Piergiovanni F, Pierro V, Pillant G, Pinard L, Pinto IM, Pitkin M, Poeld JH, Poggiani R, Popolizio P, Post A, Powell J, Prasad J, Predoi V, Premachandra SS, Prestegard T, Price LR, Prijatelj M, Principe M, Privitera S, Prix R, Prodi GA, Prokhorov L, Puncken O, Punturo M, Puppo P, Pürrer M, Qi H, Qin J, Quetschke V, Quintero EA, Quitzow-James R, Raab FJ, Rabeling DS, Radkins H, Raffai P, Raja S, Rakhmanov M, Ramet CR, Rapagnani P, Raymond V, Razzano M, Re V, Read J, Reed CM, Regimbau T, Rei L, Reid S, Reitze DH, Rew H, Reyes SD, Ricci F, Riles K, Robertson NA, Robie R, Robinet F, Rocchi A, Rolland L, Rollins JG, Roma VJ, Romano JD, Romano R, Romanov G, Romie JH, Rosińska D, Rowan S, Rüdiger A, Ruggi P, Ryan K, Sachdev S, Sadecki T, Sadeghian L, Salconi L, Saleem M, Salemi F, Samajdar A, Sammut L, Sampson LM, Sanchez EJ, Sandberg V, Sandeen B, Sanders GH, Sanders JR, Sassolas B, Sathyaprakash BS, Saulson PR, Sauter O, Savage RL, Sawadsky A, Schale P, Schilling R, Schmidt J, Schmidt P, Schnabel R, Schofield RMS, Schönbeck A, Schreiber E, Schuette D, Schutz BF, Scott J, Scott SM, Sellers D, Sengupta AS, Sentenac D, Sequino V, Sergeev A, Serna G, Setyawati Y, Sevigny A, Shaddock DA, Shaffer T, Shah S, Shahriar MS, Shaltev M, Shao Z, Shapiro B, Shawhan P, Sheperd A, Shoemaker DH, Shoemaker DM, Siellez K, Siemens X, Sigg D, Silva AD, Simakov D, Singer A, Singer LP, Singh A, Singh R, Singhal A, Sintes AM, Slagmolen BJJ, Smith JR, Smith MR, Smith ND, Smith RJE, Son EJ, Sorazu B, Sorrentino F, Souradeep T, Srivastava AK, Staley A, Steinke M, Steinlechner J, Steinlechner S, Steinmeyer D, Stephens BC, Stevenson SP, Stone R, Strain KA, Straniero N, Stratta G, Strauss NA, Strigin S, Sturani R, Stuver AL, Summerscales TZ, Sun L, Sutton PJ, Swinkels BL, Szczepańczyk MJ, Tacca M, Talukder D, Tanner DB, Tápai M, Tarabrin SP, Taracchini A, Taylor R, Theeg T, Thirugnanasambandam MP, Thomas EG, Thomas M, Thomas P, Thorne KA, Thorne KS, Thrane E, Tiwari S, Tiwari V, Tokmakov KV, Tomlinson C, Tonelli M, Torres CV, Torrie CI, Töyrä D, Travasso F, Traylor G, Trifirò D, Tringali MC, Trozzo L, Tse M, Turconi M, Tuyenbayev D, Ugolini D, Unnikrishnan CS, Urban AL, Usman SA, Vahlbruch H, Vajente G, Valdes G, Vallisneri M, van Bakel N, van Beuzekom M, van den Brand JFJ, Van Den Broeck C, Vander-Hyde DC, van der Schaaf L, van Heijningen JV, van Veggel AA, Vardaro M, Vass S, Vasúth M, Vaulin R, Vecchio A, Vedovato G, Veitch J, Veitch PJ, Venkateswara K, Verkindt D, Vetrano F, Viceré A, Vinciguerra S, Vine DJ, Vinet JY, Vitale S, Vo T, Vocca H, Vorvick C, Voss D, Vousden WD, Vyatchanin SP, Wade AR, Wade LE, Wade M, Waldman SJ, Walker M, Wallace L, Walsh S, Wang G, Wang H, Wang M, Wang X, Wang Y, Ward H, Ward RL, Warner J, Was M, Weaver B, Wei LW, Weinert M, Weinstein AJ, Weiss R, Welborn T, Wen L, Weßels P, Westphal T, Wette K, Whelan JT, Whitcomb SE, White DJ, Whiting BF, Wiesner K, Wilkinson C, Willems PA, Williams L, Williams RD, Williamson AR, Willis JL, Willke B, Wimmer MH, Winkelmann L, Winkler W, Wipf CC, Wiseman AG, Wittel H, Woan G, Worden J, Wright JL, Wu G, Yablon J, Yakushin I, Yam W, Yamamoto H, Yancey CC, Yap MJ, Yu H, Yvert M, Zadrożny A, Zangrando L, Zanolin M, Zendri JP, Zevin M, Zhang F, Zhang L, Zhang M, Zhang Y, Zhao C, Zhou M, Zhou Z, Zhu XJ, Zucker ME, Zuraw SE, Zweizig J. Observation of Gravitational Waves from a Binary Black Hole Merger. PHYSICAL REVIEW LETTERS 2016; 116:061102. [PMID: 26918975 DOI: 10.1103/physrevlett.116.061102] [Citation(s) in RCA: 1373] [Impact Index Per Article: 171.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/21/2016] [Indexed: 05/04/2023]
Abstract
On September 14, 2015 at 09:50:45 UTC the two detectors of the Laser Interferometer Gravitational-Wave Observatory simultaneously observed a transient gravitational-wave signal. The signal sweeps upwards in frequency from 35 to 250 Hz with a peak gravitational-wave strain of 1.0×10(-21). It matches the waveform predicted by general relativity for the inspiral and merger of a pair of black holes and the ringdown of the resulting single black hole. The signal was observed with a matched-filter signal-to-noise ratio of 24 and a false alarm rate estimated to be less than 1 event per 203,000 years, equivalent to a significance greater than 5.1σ. The source lies at a luminosity distance of 410(-180)(+160) Mpc corresponding to a redshift z=0.09(-0.04)(+0.03). In the source frame, the initial black hole masses are 36(-4)(+5)M⊙ and 29(-4)(+4)M⊙, and the final black hole mass is 62(-4)(+4)M⊙, with 3.0(-0.5)(+0.5)M⊙c(2) radiated in gravitational waves. All uncertainties define 90% credible intervals. These observations demonstrate the existence of binary stellar-mass black hole systems. This is the first direct detection of gravitational waves and the first observation of a binary black hole merger.
Collapse
|
56
|
Mleczko J, Defort A, Kozioł JJ, Nguyen TT, Mirończyk A, Zapotoczny B, Nowak-Jary J, Gronczewska E, Marć M, Dudek MR. Limitation of tuning the antibody-antigen reaction by changing the value of pH and its consequence for hyperthermia. J Biochem 2015; 159:421-7. [PMID: 26634446 DOI: 10.1093/jb/mvv120] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2015] [Accepted: 10/17/2015] [Indexed: 01/31/2023] Open
Abstract
Distribution of the isoelectric point (pI) was calculated for the hypervariable regions of Fab fragments of the antibody molecules, which structure is annotated in the structural antibody database SabDab. The distribution is consistent with the universal for all organisms dividing the proteome into two sets of acidic and basic proteins. It shows the additional fine structure in a form of the narrow-sized peaks of pI values. This is an explanation why a small change of the environmental pH can have a strong effect on the antibody-antigen affinity. To show this, a typical enzyme-linked immunospecific assay experiment for testing the reaction of goat anti-human IgA antibodies with human IgA immunoglobulins of saliva as antigens was modified in such a way that Fe3O4magnetic nanoparticles were added to PBS buffer. The magnetic nanoparticles were remotely heated by the radio frequency magnetic field providing the local change of temperature and pH. It was observed that short times of the heating were significantly increasing the antibody-antigen binding strength while it was not the case for a longer time. The finding discussed in the study can be useful for biopharmaceuticals using antibodies, the immunoassay techniques as well as for control over the use of hyperthermia.
Collapse
|
57
|
Xu S, Nam SM, Kim JH, Das R, Choi SK, Nguyen TT, Quan X, Choi SJ, Chung CH, Lee EY, Lee IK, Wiederkehr A, Wollheim CB, Cha SK, Park KS. Palmitate induces ER calcium depletion and apoptosis in mouse podocytes subsequent to mitochondrial oxidative stress. Cell Death Dis 2015; 6:e1976. [PMID: 26583319 PMCID: PMC4670935 DOI: 10.1038/cddis.2015.331] [Citation(s) in RCA: 135] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2015] [Revised: 10/02/2015] [Accepted: 10/12/2015] [Indexed: 12/14/2022]
Abstract
Pathologic alterations in podocytes lead to failure of an essential component of the glomerular filtration barrier and proteinuria in chronic kidney diseases. Elevated levels of saturated free fatty acid (FFA) are harmful to various tissues, implemented in the progression of diabetes and its complications such as proteinuria in diabetic nephropathy. Here, we investigated the molecular mechanism of palmitate cytotoxicity in cultured mouse podocytes. Incubation with palmitate dose-dependently increased cytosolic and mitochondrial reactive oxygen species, depolarized the mitochondrial membrane potential, impaired ATP synthesis and elicited apoptotic cell death. Palmitate not only evoked mitochondrial fragmentation but also caused marked dilation of the endoplasmic reticulum (ER). Consistently, palmitate upregulated ER stress proteins, oligomerized stromal interaction molecule 1 (STIM1) in the subplasmalemmal ER membrane, abolished the cyclopiazonic acid-induced cytosolic Ca2+ increase due to depletion of luminal ER Ca2+. Palmitate-induced ER Ca2+ depletion and cytotoxicity were blocked by a selective inhibitor of the fatty-acid transporter FAT/CD36. Loss of the ER Ca2+ pool induced by palmitate was reverted by the phospholipase C (PLC) inhibitor edelfosine. Palmitate-dependent activation of PLC was further demonstrated by following cytosolic translocation of the pleckstrin homology domain of PLC in palmitate-treated podocytes. An inhibitor of diacylglycerol (DAG) kinase, which elevates cytosolic DAG, strongly promoted ER Ca2+ depletion by low-dose palmitate. GF109203X, a PKC inhibitor, partially prevented palmitate-induced ER Ca2+ loss. Remarkably, the mitochondrial antioxidant mitoTEMPO inhibited palmitate-induced PLC activation, ER Ca2+ depletion and cytotoxicity. Palmitate elicited cytoskeletal changes in podocytes and increased albumin permeability, which was also blocked by mitoTEMPO. These data suggest that oxidative stress caused by saturated FFA leads to mitochondrial dysfunction and ER Ca2+ depletion through FAT/CD36 and PLC signaling, possibly contributing to podocyte injury.
Collapse
|
58
|
Fisher J, Tran T, Nguyen TT, Nguyen H, Tran TD. Common mental disorders among women, social circumstances and toddler growth in rural Vietnam: a population-based prospective study. Child Care Health Dev 2015; 41:843-52. [PMID: 25708782 DOI: 10.1111/cch.12235] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 01/17/2015] [Indexed: 11/29/2022]
Abstract
BACKGROUND Common mental disorders (CMD) and adverse social circumstances are widespread among mothers of infants and toddlers in resource-constrained settings. These can undermine early childhood development through compromised caregiving and insufficient access to essential resources. The aim was to examine the effect of maternal CMD and social adversity in the post-partum year on toddler's length-for-age index in a rural low-income setting. METHODS A population-based prospective cohort study of women in Ha Nam province, Vietnam who completed baseline assessments in either late pregnancy or 4-6 weeks post partum and were followed up, with their toddlers, 15 months later. CMD were assessed at both points by psychiatrist-administered Structured Clinical Interviews for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Diagnoses. Anthropometric indices were calculated from toddler's age, sex, weight and length using World Health Organization Child Growth Standards. Social adversities were assessed by study-specific questions and locally validated psychometric instruments. The hypothesized model of factors governing toddler's length-for-age Z score (LAZ) was tested using path analysis. RESULTS In total, 211/234 (90.1%) mother-toddler pairs provided complete data. Baseline prevalence of CMD among women was 33.6% and follow-up was 18.5%. The mean LAZ among toddlers was -1.03 and stunting prevalence (LAZ < -2) was 15.6%. Maternal CMD at baseline were indirectly related to toddler LAZ via maternal CMD at follow-up (regression coefficient = -0.05, 95% CI -0.11 to -0.01). Maternal CMD at follow-up was associated significantly with toddler LAZ (regression coefficient = -0.15, 95% CI -0.28 to -0.05). Poorer quality of marital relationship, mothers' experiences of childhood abuse and <30 days dedicated post-partum care were associated indirectly with lower toddler LAZ via maternal CMD. CONCLUSIONS Maternal post-natal CMD are associated with child growth measured by LAZ in this resource-constrained setting. Social adversities affect child growth indirectly through increasing the risk of maternal CMD. Interventions to reduce stunting in low-income settings may need to address maternal CMD and social adversities in order to improve impact.
Collapse
|
59
|
de Carvalho Ferreira HC, Pauszek SJ, Ludi A, Huston CL, Pacheco JM, Le VT, Nguyen PT, Bui HH, Nguyen TD, Nguyen T, Nguyen TT, Ngo LT, Do DH, Rodriguez L, Arzt J. An Integrative Analysis of Foot-and-Mouth Disease Virus Carriers in Vietnam Achieved Through Targeted Surveillance and Molecular Epidemiology. Transbound Emerg Dis 2015; 64:547-563. [PMID: 26301461 DOI: 10.1111/tbed.12403] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2015] [Indexed: 11/28/2022]
Abstract
Foot-and-mouth disease (FMD) is a major constraint to transboundary trade in animal products, yet much of its natural ecology and epidemiology in endemic regions is still poorly understood. To address this gap, a multidisciplinary, molecular and conventional epidemiological approach was applied to an investigation of endemic FMD in Vietnam. Within the study space, it was found that 22.3% of sampled ruminants had previously been infected with FMD virus (FMDV), of which 10.8% were persistent, asymptomatic carriers (2.4% of the total population). Descriptive data collected from targeted surveillance and a farm questionnaire showed a significantly lower prevalence of FMDV infection for dairy farms. In contrast, farms of intermediate size and/or history of infection in 2010 were at increased risk of FMD exposure. At the individual animal level, buffalo had the highest exposure risk (over cattle), and there was spatial heterogeneity in exposure risk at the commune level. Conversely, carrier prevalence was higher for beef cattle, suggesting lower susceptibility of buffalo to persistent FMDV infection. To characterize virus strains currently circulating in Vietnam, partial FMDV genomic (VP1) sequences from carrier animals collected between 2012 and 2013 (N = 27) and from FMDV outbreaks between 2009 and 2013 (N = 79) were compared by phylogenetic analysis. Sequence analysis suggested that within the study period, there were two apparent novel introductions of serotype A viruses and that the dominant lineage of serotype O in Vietnam shifted from SEA/Mya-98 to ME-SA/PanAsia. FMDV strains shared close ancestors with FMDV from other South-East Asian countries indicating substantial transboundary movement of the predominant circulating strains. Close genetic relationships were observed between carrier and outbreak viruses, which may suggest that asymptomatic carriers of FMDV contribute to regional disease persistence. Multiple viral sequences obtained from carrier cattle over a 1-year period had considerable within-animal genetic variation, indicating within-host virus evolution.
Collapse
|
60
|
Delabouglise A, Antoine-Moussiaux N, Phan TD, Dao DC, Nguyen TT, Truong BD, Nguyen XNT, Vu TD, Nguyen KV, Le HT, Salem G, Peyre M. The Perceived Value of Passive Animal Health Surveillance: The Case of Highly Pathogenic Avian Influenza in Vietnam. Zoonoses Public Health 2015; 63:112-28. [PMID: 26146982 PMCID: PMC4758386 DOI: 10.1111/zph.12212] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2015] [Indexed: 12/01/2022]
Abstract
Economic evaluations are critical for the assessment of the efficiency and sustainability of animal health surveillance systems and the improvement of their efficiency. Methods identifying and quantifying costs and benefits incurred by public and private actors of passive surveillance systems (i.e. actors of veterinary authorities and private actors who may report clinical signs) are needed. This study presents the evaluation of perceived costs and benefits of highly pathogenic avian influenza (HPAI) passive surveillance in Vietnam. Surveys based on participatory epidemiology methods were conducted in three provinces in Vietnam to collect data on costs and benefits resulting from the reporting of HPAI suspicions to veterinary authorities. A quantitative tool based on stated preference methods and participatory techniques was developed and applied to assess the non-monetary costs and benefits. The study showed that poultry farmers are facing several options regarding the management of HPAI suspicions, besides reporting the following: treatment, sale or destruction of animals. The option of reporting was associated with uncertain outcome and transaction costs. Besides, actors anticipated the release of health information to cause a drop of markets prices. This cost was relevant at all levels, including farmers, veterinary authorities and private actors of the upstream sector (feed, chicks and medicine supply). One benefit associated with passive surveillance was the intervention of public services to clean farms and the environment to limit the disease spread. Private actors of the poultry sector valued information on HPAI suspicions (perceived as a non-monetary benefit) which was mainly obtained from other private actors and media.
Collapse
|
61
|
Sasongko MB, Wong TY, Jenkins AJ, Nguyen TT, Shaw JE, Wang JJ. Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy. Diabet Med 2015; 32:686-91. [PMID: 25407692 DOI: 10.1111/dme.12640] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 11/17/2014] [Indexed: 12/12/2022]
Abstract
AIM To examine the relationships of serum markers of inflammation and endothelial function to diabetic retinopathy. METHODS We recruited 224 patients with diabetes (85 with Type 1 and 139 with Type 2 diabetes) aged 18-70 years. Serum markers of inflammation (high-sensitivity C-reactive protein) and endothelial function (soluble intercell adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin, endothelin-1 and total nitrite) were assessed using nephelometry, immunoassays and spectroscopy. Diabetic retinopathy was graded from two-field fundus photographs according to the Airlie House Classification system and was categorized into no diabetic retinopathy, mild non-proliferative diabetic retinopathy, moderate non-proliferative diabetic retinopathy and vision-threatening diabetic retinopathy, the latter comprising severe non-proliferative diabetic retinopathy, proliferative diabetic retinopathy or clinically significant macular oedema. Multinomial logistic regression was used to assess the associations between serum markers and diabetic retinopathy. RESULTS In the study, 64% of patients (144/224) had diabetic retinopathy and 25% (57/244) had vision-threatening diabetic retinopathy. After controlling for age, gender, diabetes duration, HbA1c , systolic blood pressure, total and HDL cholesterol, smoking, the use of insulin or oral hypoglycaemic agents, nephropathy and cardiovascular disease, a positive association was found between increasing high-sensitivity C-reactive protein levels and the presence of vision-threatening diabetic retinopathy (odds ratio 1.26; 95% CI 1.05-1.51, per sd increase in high-sensitivity C-reactive protein). After stratifying by BMI ( ≥ 30 and < 30 kg/m(2) ), this association was found to be more pronounced in people with a BMI ≥ 30 kg/m(2) (odds ratio 2.9; P for interaction = 0.019). No associations were found between serum markers of endothelial activation and diabetic retinopathy. CONCLUSIONS Higher C-reactive protein levels, but not markers of endothelial function, may be related to more severe diabetic retinopathy. This finding suggests that inflammatory processes are involved in severe diabetic retinopathy, particularly in patients with a BMI ≥ 30 kg/m(2) .
Collapse
|
62
|
Rancan G, Nguyen TT, Glaser SJ. Gradient ascent pulse engineering for rapid exchange saturation transfer. JOURNAL OF MAGNETIC RESONANCE (SAN DIEGO, CALIF. : 1997) 2015; 252:1-9. [PMID: 25635353 DOI: 10.1016/j.jmr.2014.12.016] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/11/2014] [Revised: 12/17/2014] [Accepted: 12/19/2014] [Indexed: 06/04/2023]
Abstract
Efforts in the clinical translation of the paraCEST contrast agent Yb-HPDO3A have prompted an investigation into saturation pulse optimality under energy constraints. The GRAPE algorithm has been adapted and implemented for saturation pulse optimization with chemical exchange. The flexibility of the methodology, both in extracting the microscopical parameter ensemble for the algorithm as well as in determining the characteristics of this new class of rising amplitude waveforms allows rapid testing and implementation. Optimal pulses achieve higher saturation efficiencies than the continuous wave gold standard for rapid and especially for variable exchange rates, as brought about by pH-catalysis. Gains of at least 5-15% without any tradeoff have been confirmed both on a spectrometer and on a clinical imager. Pool specific solutions, with pulses optimized for a specific exchange rate value, additionally increase the flexibility of the CEST ratiometric analysis. A simple experimental approach to determine close to optimal triangular pulses is presented.
Collapse
|
63
|
Do TD, Park C, Choi K, Jeong J, Nguyen TT, Nguyen DQ, Le TH, Chae C. Comparison of experimental infection with northern and southern Vietnamese strains of highly pathogenic porcine reproductive and respiratory syndrome virus. J Comp Pathol 2015; 152:227-37. [PMID: 25678425 DOI: 10.1016/j.jcpa.2014.12.002] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2014] [Revised: 10/15/2014] [Accepted: 12/08/2014] [Indexed: 11/18/2022]
Abstract
The aim of this study was to compare the virulence of northern and southern Vietnamese strains of highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) as assessed by the level of viral replication, gross and microscopical lung lesions and virus distribution in experimentally infected pigs. The northern and southern Vietnamese HP-PRRSV strains share 96.7% (non-structural protein 2) and 99.3% (open reading frame 5) nucleotide identity. On experimental challenge, approximately 50% of pigs infected with northern Vietnamese HP-PRRSV died, while death was not observed in any pigs infected with southern Vietnamese HP-PRRSV. Mean viral titres (expressed as log(10)TCID(50)/ml) were significantly (P <0.05) higher in sera and lungs from pigs infected with the northern Vietnamese HP-PRRSV than from those infected with the southern Vietnamese strain at multiple time points. Lung lesion scores and PRRSV antigen within pulmonary and lymphoid lesions were significantly (P <0.05) higher in pigs infected with northern Vietnamese HP-PRRSV than in those receiving southern Vietnamese HP-PRRSV at multiple time points. PRRSV antigens were observed in cardiac myocytes, gastric and renal tubular epithelial cells and astrocytes and microglia of white matter in the brain from pigs infected with the northern Vietnamese HP-PRRSV strain only. Thus, genetic similarity did not predict the degree of virulence of these strains. Northern Vietnamese HP-PRRSV was more virulent and had extended tissue tropism when compared with southern Vietnamese HP-PRRSV.
Collapse
|
64
|
Do TD, Park C, Choi K, Jeong J, Vo MK, Nguyen TT, Chae C. Comparison of pathogenicity of highly pathogenic porcine reproductive and respiratory syndrome virus between wild and domestic pigs. Vet Res Commun 2015; 39:79-85. [PMID: 25634036 DOI: 10.1007/s11259-015-9628-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2014] [Accepted: 01/21/2015] [Indexed: 11/26/2022]
Abstract
The objective of this study was to compare the pathogenicity of highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) infection between wild and domestic pigs based on clinical, immunological, and pathological evaluation. Upon challenge with HP-PRRSV, five wild pigs died compared to none of the domestic. Anti-PRRSV antibody titers were significantly (P < 0.05) higher in wild HP-PRRSV-infected pigs versus the domestic HP-PRRSV-infected pigs at 21 days post inoculation (dpi). Lung lesion scores at 7 dpi were also significantly (P < 0.01) higher in domestic infected pigs than wild infected pigs. The most striking difference was the viral tissue distribution between the wild and domestic HP-PRRSV-infected pigs. HP-PRRSV-positive cells were observed in bronchiolar, gastric, and renal tubular epithelial cells from wild HP-PRRSV-infected pigs only. The results in this study demonstrated a genetic difference exists between wild and domestic pigs, which could results in different clinical signs, immunological responses, and pathological outcomes to HP-PRRSV infection.
Collapse
|
65
|
Nguyen T, Argyrakis A, Nguyen TT, Eckel H, Vogelsberger W. EHMTI-0263. WHO step scheme into combination with a therapeutical local anesthesia (TLA), physiotherapy, TENs, phytotherapy, acupressure, acupuncture for chronically therapy resistant trigeminal neuralgia after Trang. J Headache Pain 2014. [PMCID: PMC4180593 DOI: 10.1186/1129-2377-15-s1-c47] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
66
|
Martel A, Blooi M, Adriaensen C, Van Rooij P, Beukema W, Fisher MC, Farrer RA, Schmidt BR, Tobler U, Goka K, Lips KR, Muletz C, Zamudio KR, Bosch J, Lötters S, Wombwell E, Garner TWJ, Cunningham AA, Spitzen-van der Sluijs A, Salvidio S, Ducatelle R, Nishikawa K, Nguyen TT, Kolby JE, Van Bocxlaer I, Bossuyt F, Pasmans F. Wildlife disease. Recent introduction of a chytrid fungus endangers Western Palearctic salamanders. Science 2014; 346:630-1. [PMID: 25359973 DOI: 10.1126/science.1258268] [Citation(s) in RCA: 299] [Impact Index Per Article: 29.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Abstract
Emerging infectious diseases are reducing biodiversity on a global scale. Recently, the emergence of the chytrid fungus Batrachochytrium salamandrivorans resulted in rapid declines in populations of European fire salamanders. Here, we screened more than 5000 amphibians from across four continents and combined experimental assessment of pathogenicity with phylogenetic methods to estimate the threat that this infection poses to amphibian diversity. Results show that B. salamandrivorans is restricted to, but highly pathogenic for, salamanders and newts (Urodela). The pathogen likely originated and remained in coexistence with a clade of salamander hosts for millions of years in Asia. As a result of globalization and lack of biosecurity, it has recently been introduced into naïve European amphibian populations, where it is currently causing biodiversity loss.
Collapse
|
67
|
Nguyen TT, Herrmann AJ, Troyer M, Pilati S. Critical temperature of interacting Bose gases in periodic potentials. PHYSICAL REVIEW LETTERS 2014; 112:170402. [PMID: 24836222 DOI: 10.1103/physrevlett.112.170402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/04/2013] [Indexed: 06/03/2023]
Abstract
The superfluid transition of a repulsive Bose gas in the presence of a sinusoidal potential which represents a simple-cubic optical lattice is investigated using quantum Monte Carlo simulations. At the average filling of one particle per well the critical temperature has a nonmonotonic dependence on the interaction strength, with an initial sharp increase and a rapid suppression at strong interactions in the vicinity of the Mott transition. In an optical lattice the positive shift of the transition is strongly enhanced compared to the homogenous gas. By varying the lattice filling we find a crossover from a regime where the optical lattice has the dominant effect to a regime where interactions dominate and the presence of the lattice potential becomes almost irrelevant.
Collapse
|
68
|
Jarick I, Volckmar AL, Pütter C, Pechlivanis S, Nguyen TT, Dauvermann MR, Beck S, Albayrak Ö, Scherag S, Gilsbach S, Cichon S, Hoffmann P, Degenhardt F, Nöthen MM, Schreiber S, Wichmann HE, Jöckel KH, Heinrich J, Tiesler CMT, Faraone SV, Walitza S, Sinzig J, Freitag C, Meyer J, Herpertz-Dahlmann B, Lehmkuhl G, Renner TJ, Warnke A, Romanos M, Lesch KP, Reif A, Schimmelmann BG, Hebebrand J, Scherag A, Hinney A. Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder. Mol Psychiatry 2014; 19:115-21. [PMID: 23164820 PMCID: PMC3873032 DOI: 10.1038/mp.2012.161] [Citation(s) in RCA: 63] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/14/2011] [Revised: 09/21/2012] [Accepted: 10/09/2012] [Indexed: 12/12/2022]
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a common, highly heritable neurodevelopmental disorder. Genetic loci have not yet been identified by genome-wide association studies. Rare copy number variations (CNVs), such as chromosomal deletions or duplications, have been implicated in ADHD and other neurodevelopmental disorders. To identify rare (frequency ≤1%) CNVs that increase the risk of ADHD, we performed a whole-genome CNV analysis based on 489 young ADHD patients and 1285 adult population-based controls and identified one significantly associated CNV region. In tests for a global burden of large (>500 kb) rare CNVs, we observed a nonsignificant (P=0.271) 1.126-fold enriched rate of subjects carrying at least one such CNV in the group of ADHD cases. Locus-specific tests of association were used to assess if there were more rare CNVs in cases compared with controls. Detected CNVs, which were significantly enriched in the ADHD group, were validated by quantitative (q)PCR. Findings were replicated in an independent sample of 386 young patients with ADHD and 781 young population-based healthy controls. We identified rare CNVs within the parkinson protein 2 gene (PARK2) with a significantly higher prevalence in ADHD patients than in controls (P=2.8 × 10(-4) after empirical correction for genome-wide testing). In total, the PARK2 locus (chr 6: 162 659 756-162 767 019) harboured three deletions and nine duplications in the ADHD patients and two deletions and two duplications in the controls. By qPCR analysis, we validated 11 of the 12 CNVs in ADHD patients (P=1.2 × 10(-3) after empirical correction for genome-wide testing). In the replication sample, CNVs at the PARK2 locus were found in four additional ADHD patients and one additional control (P=4.3 × 10(-2)). Our results suggest that copy number variants at the PARK2 locus contribute to the genetic susceptibility of ADHD. Mutations and CNVs in PARK2 are known to be associated with Parkinson disease.
Collapse
|
69
|
Nguyen TT, Ngo HH, Guo WS. Effect of sponge volume fraction on the performance of a novel fluidized bed bioreactor. WATER SCIENCE AND TECHNOLOGY : A JOURNAL OF THE INTERNATIONAL ASSOCIATION ON WATER POLLUTION RESEARCH 2013; 67:2645-2650. [PMID: 23752401 DOI: 10.2166/wst.2013.169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
A novel fluidized bed bioreactor (FBBR) was designed by integration of anaerobic granular activated carbon and aerobic sponge reactors. This FBBR was evaluated at different sponge volume fractions for treating a synthetic wastewater. Polyester urethane sponge with cube size of 1 × 1 × 1 cm and density of 28-30 kg/m(3) with 90 cells per 25 mm was used as biomass carrier. The results indicate that the FBBR could remove more than 93% of dissolved organic carbon (DOC). The highest nutrient removal efficiencies (58.2% PO4-P and 75.4% NH4-N) were achieved at 40% sponge volume fraction. The system could provide a good condition for biomass growth (e.g. 186.2 mg biomass/g sponge). No significant different performance in specific oxygen uptake rate was observed between 30, 40, and 50% sponge volume fractions.
Collapse
|
70
|
Deetz CO, Scott MG, Ladenson JH, Seyoum M, Hassan A, Kreisel FH, Nguyen TT, Frater JL. Use of a United States-based laboratory as a hematopathology reference center for a developing country: logistics and results. Int J Lab Hematol 2012; 35:77-81. [PMID: 22938565 DOI: 10.1111/ijlh.12001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2011] [Accepted: 07/16/2012] [Indexed: 11/28/2022]
Abstract
INTRODUCTION With proper logistical support and sponsorship, a laboratory in an industrialized nation might be able to act as a reference laboratory for clinicians based in a developing country. METHODS We built on previous experience in the clinical laboratory to see whether a specialized histopathology service (hematopathology) could be provided to a developing country without the expertise or experience to do it in country. RESULTS Over an 13-year period, 582 cases from 579 individuals were analyzed. Principal pathologic findings included acute leukemia in 84 cases (14%), dyspoiesis in one or more of the hematopoietic lineages in 65 cases (11%, including three cases with high-grade myelodysplasia), 23 cases (4%) with findings suspicious for a chronic myeloproliferative disorder, 35 cases (6%) with findings suspicious for a lymphoproliferative disorder, and infectious organisms (presumably Leishmania in most instances) in 9 (1%) of cases. Specimens from 45 cases (8%) were unsatisfactory owing to extreme hemodilution and/or specimen degeneration. CONCLUSION With proper support, a medical laboratory in an industrialized nation may serve as a reference facility for a developing nation. The use of existing infrastructure may be remarkably effective to achieve optimal turnaround time. Although the lack of ancillary studies and follow-up biopsies limit the ability to achieve a definitive diagnosis in many cases, this must be viewed in the context of the limited ability to diagnose or manage hematopoietic neoplasia in developing nations.
Collapse
|
71
|
Sasongko MB, Wong TY, Nguyen TT, Shaw JE, Jenkins AJ, Wang JJ. Novel versus traditional risk markers for diabetic retinopathy. Diabetologia 2012; 55:666-70. [PMID: 22198262 DOI: 10.1007/s00125-011-2424-x] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/07/2011] [Accepted: 11/30/2011] [Indexed: 10/14/2022]
Abstract
AIMS/HYPOTHESIS To explore the relative contribution of novel and traditional risk markers for diabetic retinopathy (DR). METHODS A clinic-based study of 224 diabetic patients (85 type 1, 139 type 2) from a diabetes clinic was performed. DR was graded from fundus photographs according to the Airlie House Classification system and classified as absent or present (at least ETDRS level 14). Novel risk markers assessed included serum apolipoprotein (Apo) AI and B, skin microvascular responses to acetylcholine (endothelium-dependent) and sodium nitroprusside (endothelium-independent) iontophoresis, flicker-light-induced retinal vasodilation and retinal vascular tortuosity. Relative contribution was determined by semi-partial correlation coefficient generated from a logistic regression model containing all traditional and novel risk markers simultaneously. RESULTS There were 144 (64.3%) participants with DR. Of the novel markers, ApoAI, flicker-light-induced vasodilation and retinal arteriolar tortuosity were significantly associated with DR, independently of traditional measures (all p < 0.03). Diabetes duration contributed most (51%) to the risk of DR, followed by ApoAI (16%), systolic blood pressure (13%), retinal arteriolar tortuosity (8%) and flicker-light-induced venular and arteriolar dilation (3% and 0.5%, respectively). CONCLUSIONS/INTERPRETATION ApoAI and retinal arteriolar tortuosity made considerable contributions to DR risk, independently of traditional risk markers. Findings from this study suggest that serum ApoAI and retinal arteriolar tortuosity may be novel and independent risk markers of DR.
Collapse
|
72
|
Sheen E, Trinh HN, Nguyen TT, Do ST, Tran P, Nguyen HA, Nguyen KK, Garcia RT, Nguyen MH. The efficacy of entecavir therapy in chronic hepatitis B patients with suboptimal response to adevofir. Aliment Pharmacol Ther 2011; 34:767-74. [PMID: 21806648 DOI: 10.1111/j.1365-2036.2011.04785.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
BACKGROUND An increasing number of patients with chronic hepatitis B (CHB) have experienced treatment failure to adefovir (ADV) and their management poses a growing challenge. Very limited data are available on the efficacy of entecavir (ETV) in patients previously treated with ADV. AIM To examine the effect of ETV monotherapy on HBV DNA and ALT levels in CHB patients previously treated with ADV, but switched to ETV due to suboptimal response. METHODS Study candidates were enrolled from five community gastroenterology clinics in the U.S. Each completed at least 12 months of ETV treatment after being previously treated with ADV and experiencing suboptimal response. Primary and secondary outcome measurements were complete viral suppression (CVS, HBV DNA <100 IU/mL) and biochemical response (BR, ALT < 40 U/L), respectively. RESULTS A total of 60 patients were included in this analysis. Twelve were lamivudine (LAM)-experienced and none were LAM-resistant. At time of switch to ETV, no patients had experienced CVS. The CVS rate was 68% after 12 months of ETV therapy. The BR rate was 67% at switch to ETV and 80% after 12 months. There was no significant difference in response rates between LAM-experienced and naïve patients. Among the eight patients with ADV resistance, each achieved CVS after 12 months of ETV therapy and seven achieved BR. CONCLUSIONS In patients with suboptimal response to adefovir, complete viral suppression and biochemical response can be achieved in the majority by 12 months after switching to entecavir, including patients with prior exposure to lamivudine and those with adefovir resistance.
Collapse
|
73
|
Sasongko MB, Wong TY, Nguyen TT, Cheung CY, Shaw JE, Wang JJ. Retinal vascular tortuosity in persons with diabetes and diabetic retinopathy. Diabetologia 2011; 54:2409-16. [PMID: 21625945 DOI: 10.1007/s00125-011-2200-y] [Citation(s) in RCA: 113] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/08/2011] [Accepted: 04/29/2011] [Indexed: 10/18/2022]
Abstract
AIM/HYPOTHESIS The aim of this hypothesis was to examine the association of retinal vessel tortuosity with diabetes and diabetic retinopathy (DR). METHODS A clinic-based study of 327 participants (224 with diabetes and 103 non-diabetic controls) aged ≥ 18 years. DR was graded from fundus photographs according to the modified Airlie House Classification system and categorised into mild non-proliferative DR (NPDR), moderate NPDR and vision-threatening DR (VTDR). Retinal vessel tortuosity was measured from disc-centred retinal photographs. Measurements were taken, using a semi-automated computer program by a single grader, of arterioles and venules within 0.5 to 2 disc diameters away from the optic disc. RESULTS There were 114 (44%) participants with DR. In the multivariate analysis, retinal arteriolar and venular tortuosity were increased in participants with diabetes without DR (mean difference 12.4 × 10(-5) and 13.3 × 10(-5), respectively; both p < 0.05) and in those with DR (mean difference 15.4 × 10(-5) and 15.0 × 10(-5), respectively; both p < 0.01) compared with non-diabetic participants. Among participants with diabetes, increased arteriolar tortuosity was significantly associated with mild NPDR (OR 1.53, 95% CI 1.03-2.05, per SD increase in arteriolar tortuosity) and moderate NPDR (OR 1.67, 95% CI 1.10-2.55) but not VTDR (OR 0.91, 95% CI 0.54-1.54). No association with DR was found for venular tortuosity. CONCLUSIONS/INTERPRETATION Persons with diabetes had more tortuous retinal vasculature than persons without diabetes. In persons with diabetes, increased arteriolar tortuosity was associated with mild and moderate stages of DR. This suggests that retinal vascular tortuosity might be an early indicator of microvascular damage in diabetes; thus, further investigation is indicated.
Collapse
|
74
|
Klco JM, Welch JS, Nguyen TT, Hurley MY, Kreisel FH, Hassan A, Lind AC, Frater JL. State of the art in myeloid sarcoma. Int J Lab Hematol 2011; 33:555-65. [PMID: 21883967 DOI: 10.1111/j.1751-553x.2011.01361.x] [Citation(s) in RCA: 79] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
INTRODUCTION Myeloid sarcomas are extramedullary lesions composed of myeloid lineage blasts that typically form tumorous masses and may precede, follow, or occur in the absence of systemic acute myeloid leukemia. They most commonly involve the skin and soft tissues, lymph nodes, and gastrointestinal tract and are particularly challenging to diagnose in patients without an antecedent history of acute myeloid leukemia. METHODS We conducted a search of the English language medical literature for recent studies of interest to individuals involved in the diagnosis of myeloid sarcoma. RESULTS The differential diagnosis includes non-Hodgkin lymphoma, blastic plasmacytoid dendritic cell neoplasm, histiocytic sarcoma, melanoma, carcinoma, and (in children) small round blue cell tumors. The sensitivity and specificity of immunohistochemical markers must be considered when evaluating a suspected case of myeloid sarcoma. A high percentage of tested cases have cytogenetic abnormalities. CONCLUSION A minimal panel of immunohistochemical markers should include anti-CD43 or anti-lysozyme as a lack of immunoreactivity for either of these sensitive markers would be inconsistent with a diagnosis of myeloid sarcoma. Use of more specific markers of myeloid disease, such as CD33, myeloperoxidase, CD34 and CD117 is necessary to establish the diagnosis. Other antibodies may be added depending on the differential diagnosis. Identification of acute myeloid leukemia-associated genetic lesions may be helpful in arriving at the correct diagnosis.
Collapse
|
75
|
Rosenstock J, Lewin AJ, Norwood P, Somayaji V, Nguyen TT, Teeter JG, Johnson SL, Dai H, Terra SG. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor PF-734200 added to metformin in Type 2 diabetes. Diabet Med 2011; 28:464-9. [PMID: 21392067 DOI: 10.1111/j.1464-5491.2010.03181.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
AIMS PF-734200 is a potent and selective oral dipeptidyl peptidase-4 (DPP-4) inhibitor. This study assessed the efficacy and safety of PF-734200 at dose rates of 20 and 30 mg/day in subjects with Type 2 diabetes mellitus inadequately controlled on metformin monotherapy. METHODS This was a placebo-controlled, double-blind, randomized, multicentre, 12 week study. Subjects with Type 2 diabetes mellitus were eligible if screening glycosylated haemoglobin (HbA(1c) ) was 7-11% (53.0-96.7 mmol/mol) and they had been receiving metformin monotherapy for ≥2 months. Subjects receiving metformin and an insulin secretagogue or metformin and thiazolidinedione needed to have a screening HbA(1c) of 6.5-9.5% (47.5-80.3 mmol/mol), measured prior to discontinuing the insulin secretagogue or thiazolidinedione. The primary end-point of the study was a change from baseline to week 12 in HbA(1c) levels. RESULTS Baseline characteristics for 289 subjects randomized to PF-734200 or placebo groups were similar (mean age 56.5 years, mean body mass index 32.2 kg/m(2) and mean HbA(1c) 8.2%, 66.1 mmol/mol). In the predefined per protocol data set, least-squares mean HbA(1c) at week 12 was reduced by 0.79 (8.6 mmol/mol 95% confidence interval -1.10 to -0.49, -12.0 to -5.4 mmol/mol) and 0.92% (10.1 mmol/mol; -1.23 to -0.61, -13.4 to -6.7 mmol/mol) in the 20 and 30 mg groups, respectively, compared with placebo. Differences from placebo were statistically significant (P<0.0001), but the differences between the 20 and 30 mg groups were not. The intent-to-treat analysis yielded similar findings. CONCLUSIONS The HbA(1c) was significantly and meaningfully reduced by both doses of PF-734200, but 20 mg appears to be the more appropriate therapeutic dose for Type 2 diabetes mellitus, contingent upon confirmation by long-term controlled studies.
Collapse
|